Basic Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. May 7, 2019; 25(17): 2071-2085
Published online May 7, 2019. doi: 10.3748/wjg.v25.i17.2071
Figure 5
Figure 5 Co-expression of A20/tumor necrosis factor receptor 1-associated death domain in the intestinal epithelium of mice across groups. A: Wild-type mice in normal control group; B: Wild-type mice in model control group; C: Wild-type mice in mesalazine group; D: Wild-type mice in herbs-partitioned moxibustion group; E: A20IEC-KO mice in normal control group; F: A20IEC-KO mice in model control group; G: A20IEC-KO mice in mesalazine group; H: A20IEC-KO mice in herbs-partitioned moxibustion group. Data are presented as the mean ± standard deviation (n = 10). Data were evaluated for statistical significance using one-way analysis of variance and are represented as follows: aP < 0.05, bP < 0.01 as compared to normal contro; cP < 0.05, dP < 0.01 as compared to model control; eP < 0.05, fP < 0.01 as compared to mesalazine; gP < 0.05, hP < 0.01 as compared to wild type. TRADD: Tumor necrosis factor receptor 1-associated death domain; WT: Wild type; NC: Normal control; MC: Model control; MESA: Mesalazine; HPM: Herbs-partitioned moxibustion.